Balance Sheet for Vir Biotechnology Inc. (VIR)

$ 35.53   -0.24 (-0.67%) Volume: 889.01k 4:00 PM EDT 27-Oct-2020
After Hours:  $ 35.60   0.07 (+0.20%) Volume: 5.72k 6:03 PM EDT 27-Oct-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017
Cash and Equivalents 109,335 47,598 187,918
Restrictable Cash 6,181 10,761 -
Marketable Securities 274,101 50,845 -
Accounts Receivable - - -
Loans Receivable - - -
Other Receivables - - -
Receivables - - -
Inventories, Raw Materials - - -
Inventories, Work in Progress - - -
Inventories, Purchased Components - - -
Inventories, Finished Goods - - -
Inventories, Other - - -
Inventories, Adjustments & Allowances - - -
Inventories - - -
Prepaid Expenses 13,378 8,579 4,432
Current Deferred Income Taxes - - -
Other Current Assets - - -
Total Current Assets 402,995 117,783 192,350
Land and Improvements - - -
Buildings and Improvement 7,121 3,114 2,010
Machinery, Furniture and Equipment 13,877 8,999 3,208
Construction in Progress 142 1,893 186
Fixed Assets, Other - - -
Fixed Assets, Total 21,140 14,006 5,404
Gross Fixed Assets 21,140 14,006 5,404
Accumulated Depreciation (4,832) (1,716) (266)
Net Fixed Assets 16,308 12,290 5,138
Intangibles 35,694 36,917 35,882
Cost in Excess 16,937 16,937 16,937
Non-Current Deferred Income Taxes - - -
Other Non-Current Assets 15,847 7,669 1,259
Total Non-Current Assets 109,076 73,813 59,216
Total Assets 512,071 191,596 251,566
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017
Accounts Payable 5,881 6,473 4,898
Short Term Debt 237 - -
Notes Payable - - -
Accrued Expenses 24,824 14,534 7,540
Accrued Liabilities 24,824 14,534 7,540
Deferred Revenues 6,181 8,761 -
Current Deferred Income Taxes - (480) (10,924)
Other Current Liabilities 22,083 10,140 -
Total Current Liabilities 59,206 39,908 12,438
Long Term Debt N/A N/A N/A
Deferred Income Tax 3,305 3,305 3,305
Other Non-Current Liabilities 25,618 18,423 12,214
Minority Interest - - -
Capital Lease Obligations - - -
Preferred Securities of Subsidiary Trust - - -
Preferred Equity Outside Shareholders' Equity - 309,137 292,525
Total Non-Current Liabilities 28,923 330,865 308,044
Total Liabilities 88,129 370,773 320,482
Preferred Shareholder's Equity - - -
Common Shareholder's Equity 423,942 (179,177) (68,916)
Common Par 11 1 1
Additional Paid in Capital 793,051 14,672 9,035
Cumulative Translation Adjustments - - -
Retained Earnings (368,519) (193,836) (77,952)
Treasury Stock - - -
Other Equity Adjustments (601) (14) -
Total Capitalization 423,942 (179,177) (68,916)
Total Equity 423,942 (179,177) (68,916)
Total Liabilities & Shareholder's Equity 512,071 191,596 251,566
Cash Flow (178,237) (118,217) (69,852)
Working Capital 343,789 77,875 179,912
Free Cash Flow (138,572) (102,288) (69,123)
Invested Capital 423,942 (179,177) (68,916)
Shares Outstanding - Common Class Only 107,649 - -
Preferred Shares Outstanding - - -
Total Ordinary Shares 107,649 109,397 109,397
Total Common Shares Outstanding 107,649 - -
Treasury Shares - - -
Basic Weighted Shares Outstanding 30,350 96,913 96,913
Diluted Weighted Shares Outstanding 30,350 96,913 96,913